Financial Symmetry Inc Provectus Biopharmaceuticals, Inc. Transaction History
Financial Symmetry Inc
- $143 Billion
- Q3 2024
A detailed history of Financial Symmetry Inc transactions in Provectus Biopharmaceuticals, Inc. stock. As of the latest transaction made, Financial Symmetry Inc holds 10,191 shares of PVCT stock, worth $1,121. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,191
Previous 10,191
-0.0%
Holding current value
$1,121
Previous $1.29 Million
22.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PVCT
# of Institutions
7Shares Held
227KCall Options Held
0Put Options Held
0-
Home Federal Bank Of Tennessee100KShares$11,0000.0% of portfolio
-
Lee Danner & Bass Inc50KShares$5,5000.0% of portfolio
-
Atlas Wealth LLC Cincinnati, OH26.6KShares$2,9280.0% of portfolio
-
Lbmc Investment Advisors, LLC20KShares$2,2000.0% of portfolio
-
Academy Capital Management Inc Waco, TX20KShares$2,2000.0% of portfolio
About PROVECTUS BIOPHARMACEUTICALS, INC.
- Ticker PVCT
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 419,496,992
- Market Cap $46.1M
- Description
- Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal ...